28067693|t|Intraoperative ketamine reduces immediate postoperative opioid consumption after spinal fusion surgery in chronic pain patients with opioid dependency: a randomized, blinded trial
28067693|a|Perioperative handling of surgical patients with opioid dependency represents an important clinical problem. Animal studies suggest that ketamine attenuates central sensitization and hyperalgesia and thereby reduces postoperative opioid tolerance. We hypothesized that intraoperative ketamine would reduce immediate postoperative opioid consumption compared with placebo in chronic pain patients with opioid dependency undergoing lumbar spinal fusion surgery. Primary outcome was morphine consumption 0 to 24 hours postoperatively. Secondary outcomes were acute pain at rest and during mobilization 2 to 24 hours postoperatively (visual analogue scale), adverse events, and persistent pain 6 months postoperatively. One hundred fifty patients were randomly assigned to intraoperative S-ketamine bolus 0.5 mg/kg and infusion 0.25 mg·kg·h or placebo. Postoperatively, patients received their usual opioids, paracetamol and IV patient-controlled analgesia with morphine. In the final analyses, 147 patients were included. Patient-controlled analgesia IV morphine consumption 0 to 24 hours postoperatively was significantly reduced in the ketamine group compared with the placebo group: 79 (47) vs 121 (53) mg IV, mean difference 42 mg (95% confidence interval -59 to -25), P < 0.001. Sedation was significantly reduced in the ketamine group 6 and 24 hours postoperatively. There were no significant differences regarding acute pain, nausea, vomiting, hallucinations, or nightmares. Back pain at 6 months postoperatively compared with preoperative pain was significantly more improved in the ketamine group compared with the placebo group, P = 0.005. In conclusion, intraoperative ketamine significantly reduced morphine consumption 0 to 24 hours after lumbar fusion surgery in opioid - dependent patients. The trend regarding less persistent pain 6 months postoperatively needs further investigation.
28067693	15	23	ketamine	T103	UMLS:C0022614
28067693	56	62	opioid	T103	UMLS:C0002772
28067693	81	102	spinal fusion surgery	T058	UMLS:C0919636
28067693	106	118	chronic pain	T033	UMLS:C0150055
28067693	133	139	opioid	T103	UMLS:C0002772
28067693	154	164	randomized	T062	UMLS:C0034656
28067693	166	179	blinded trial	T062	UMLS:C2347038
28067693	194	202	handling	T033	UMLS:C1832073
28067693	229	235	opioid	T103	UMLS:C0002772
28067693	280	287	problem	T033	UMLS:C0033213
28067693	289	303	Animal studies	T204	UMLS:C0683949
28067693	317	325	ketamine	T103	UMLS:C0022614
28067693	337	358	central sensitization	T038	UMLS:C2938905
28067693	363	375	hyperalgesia	T033	UMLS:C0020429
28067693	410	416	opioid	T103	UMLS:C0002772
28067693	464	472	ketamine	T103	UMLS:C0022614
28067693	510	516	opioid	T103	UMLS:C0002772
28067693	543	550	placebo	T103	UMLS:C1696465
28067693	554	566	chronic pain	T033	UMLS:C0150055
28067693	581	587	opioid	T103	UMLS:C0002772
28067693	610	638	lumbar spinal fusion surgery	T058	UMLS:C0186045
28067693	660	668	morphine	T103	UMLS:C0026549
28067693	736	754	acute pain at rest	T033	UMLS:C0234253
28067693	766	778	mobilization	T058	UMLS:C0185112
28067693	810	831	visual analogue scale	T058	UMLS:C3536884
28067693	834	848	adverse events	T038	UMLS:C0877248
28067693	865	869	pain	T033	UMLS:C0030193
28067693	928	945	randomly assigned	T062	UMLS:C0034656
28067693	964	974	S-ketamine	T103	UMLS:C2825616
28067693	975	1003	bolus 0.5 mg/kg and infusion	T058	UMLS:C1511237
28067693	1020	1027	placebo	T103	UMLS:C1696465
28067693	1076	1083	opioids	T103	UMLS:C0002772
28067693	1085	1096	paracetamol	T103	UMLS:C0000970
28067693	1104	1132	patient-controlled analgesia	T058	UMLS:C0078944
28067693	1138	1146	morphine	T103	UMLS:C0026549
28067693	1155	1169	final analyses	T170	UMLS:C3899115
28067693	1199	1227	Patient-controlled analgesia	T058	UMLS:C0078944
28067693	1231	1239	morphine	T103	UMLS:C0026549
28067693	1315	1323	ketamine	T103	UMLS:C0022614
28067693	1348	1355	placebo	T103	UMLS:C1696465
28067693	1461	1469	Sedation	T033	UMLS:C0235195
28067693	1503	1511	ketamine	T103	UMLS:C0022614
28067693	1598	1608	acute pain	T033	UMLS:C0184567
28067693	1610	1616	nausea	T033	UMLS:C0027497
28067693	1618	1626	vomiting	T033	UMLS:C0042963
28067693	1628	1642	hallucinations	T038	UMLS:C0018524
28067693	1647	1657	nightmares	T033	UMLS:C0028084
28067693	1659	1668	Back pain	T033	UMLS:C0004604
28067693	1724	1728	pain	T033	UMLS:C0030193
28067693	1752	1760	improved	T033	UMLS:C0184511
28067693	1768	1776	ketamine	T103	UMLS:C0022614
28067693	1801	1808	placebo	T103	UMLS:C1696465
28067693	1857	1865	ketamine	T103	UMLS:C0022614
28067693	1888	1896	morphine	T103	UMLS:C0026549
28067693	1929	1950	lumbar fusion surgery	T058	UMLS:C0186045
28067693	1954	1960	opioid	T103	UMLS:C0002772
28067693	2019	2023	pain	T033	UMLS:C0030193
28067693	2055	2062	further	T082	UMLS:C1517331